shortagewatch

Home / Topiramate / Australia

AU ATC N03AX11 · updated 2 Nov 2026

Topiramate shortage in Australia

Is there a Topiramate shortage in Australia?

Yes. As of 2 Nov 2026, 16 Topiramate products are reported short in Australia, the first since 30 Apr 2024. The company estimate for the return is 20 Nov 2026 (latest 23 Apr 2027). Main reason: not stated.

Also short in Canada, Italy, Spain, Austria, Belgium, Czechia, Sweden. All countries.

Affected products in Australia

CountryProductCompanySinceExpected backReason
AUNOUMED TOPIRAMATE topiramate 100 mg tablet bottle30 Apr 202431 Dec 2026Not stated
AUNOUMED TOPIRAMATE topiramate 200 mg tablet bottle30 Jun 202431 Dec 2026Not stated
AUNOUMED TOPIRAMATE topiramate 25 mg tablet bottle30 Jun 202431 Dec 2026Not stated
AUNOUMED TOPIRAMATE topiramate 50 mg tablet bottle30 Jun 202431 Dec 2026Not stated
AUEPIRAMAX 100 topiramate 100 mg tablets blister pack limited7 May 202615 Jan 2027Not stated
AUEPIRAMAX 25 topiramate 25 mg tablets blister pack limited7 May 202615 Jan 2027Not stated
AUEPIRAMAX 50 topiramate 50 mg tablets blister pack limited7 May 202615 Jan 2027Not stated
AUTAMATE topiramate 50mg tablet blister pack limited3 Jul 202631 Mar 2027Not stated
AUTAMATE topiramate 25mg tablet blister pack limited27 Aug 202630 Mar 2027Not stated
AUAPO-TOPIRAMATE topiramate 25 mg tablet blister pack limited3 Sep 20269 Apr 2027Not stated
AUTAMATE topiramate 100mg tablet blister pack limited28 Sep 202630 Mar 2027Not stated
AURBX TOPIRAMATE topiramate 50 mg tablets bottle1 Oct 202631 Dec 2026Not stated
AUTOPAMAX topiramate 50 mg tablet blister pack limited12 Oct 202620 Nov 2026Not stated
AUTOPIRAMATE-WGR topiramate 25 mg tablet blister pack anticipated20 Nov 202623 Apr 2027Not stated
AUAPO-TOPIRAMATE topiramate 200 mg tablet blister pack anticipated11 Dec 20269 Apr 2027Not stated
AUTOPIRAMATE SANDOZ topiramate 100 mg tablet bottle anticipated21 Dec 202629 Mar 2027Not stated

Source

Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.